R21/Matrix-M™ Malaria Vaccine Granted Prequalification by World Health Organization

Sample article from our Health Care Sector

December 21, 2023 (press release) –

The World Health Organization (WHO) announced today that it has prequalified the R21/Matrix-M™ malaria vaccine to prevent malaria disease in children caused by the P. falciparum parasite in endemic areas. Prequalification status enables United Nations agencies to procure the vaccine for eligible countries and will enable global rollout of the vaccine.

Prequalification is based on WHO recommendation and advice from its Strategic Advisory Group of Experts and Malaria Policy Advisory Group, which reviewed data from a Phase 3 clinical trial conducted in four African countries with 4,800 children aged 5-36 months. A manuscript describing the results of the trial has been posted to Preprints with the Lancet and is currently undergoing peer review.

Developed by University of Oxford and Serum Institute of India, the vaccine leverages Novavax’s saponin-based Matrix-M adjuvant. The R21/Matrix-M vaccine is one of several ongoing collaborations involving Novavax’s adjuvant technology, including additional research in malaria and other infectious diseases in both humans and animals.

According to the WHO, there were 249 million cases of malaria in 2022. Approximately 94% of the cases were in Africa, with children under the age of five accounting for about 78% of deaths in the region.1

The vaccine is approved for use by regulators in Ghana, Nigeria and Burkina Faso.

More information about the R21/Matrix-M vaccine may be found here.

 

WHO World Malaria report 2023

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order health care sector coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.